<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="8838" id="root" date="1996-08-22" xml:lang="en">
<title>USA: Unigene starts FORTICAL Phase III trials.</title>
<headline>Unigene starts FORTICAL Phase III trials.</headline>
<dateline>FAIRFIELD, N.J. 1996-08-22</dateline>
<text>
<p>Unigene Laboratories Inc said on Thursday it has begun Phase III clinical trials for FORTICAL Injection in the U.S. and U.K.</p>
<p>The trials are being conducted under an application allowed by the U.S. Food and Drug Administration and the U.K. Clinical Trials Exemption Scheme, a fast track route for permission to conduct clinical trials.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25670">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-22"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-08-22"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-08-22"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="FAIRFIELD, N.J."/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
